Josefa Ibáñez

652 total citations
35 papers, 433 citations indexed

About

Josefa Ibáñez is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Josefa Ibáñez has authored 35 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Josefa Ibáñez's work include Global Cancer Incidence and Screening (18 papers), Colorectal Cancer Screening and Detection (14 papers) and Cervical Cancer and HPV Research (4 papers). Josefa Ibáñez is often cited by papers focused on Global Cancer Incidence and Screening (18 papers), Colorectal Cancer Screening and Detection (14 papers) and Cervical Cancer and HPV Research (4 papers). Josefa Ibáñez collaborates with scholars based in Spain, United States and Netherlands. Josefa Ibáñez's co-authors include Raquel Zubizarreta, Dolores Salas, D. Salas, Nieves Ascunce, Xavier Castells, María Sala, María Ederra, Laia Domingo, Teresa Barata and Joana Ferrer and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Radiology.

In The Last Decade

Josefa Ibáñez

31 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josefa Ibáñez Spain 11 356 138 126 83 81 35 433
Raquel Zubizarreta Spain 12 381 1.1× 110 0.8× 136 1.1× 98 1.2× 70 0.9× 25 457
María Ederra Spain 13 400 1.1× 174 1.3× 118 0.9× 74 0.9× 105 1.3× 29 563
Javier Louro Spain 12 241 0.7× 86 0.6× 70 0.6× 43 0.5× 77 1.0× 30 400
Patrizia Falini Italy 11 370 1.0× 103 0.7× 55 0.4× 79 1.0× 26 0.3× 17 433
Amanda Dibden United Kingdom 7 202 0.6× 61 0.4× 74 0.6× 34 0.4× 86 1.1× 9 342
Jian-Jun He China 8 287 0.8× 57 0.4× 193 1.5× 83 1.0× 24 0.3× 10 437
Mehmet Ali Ergün United States 9 342 1.0× 72 0.5× 127 1.0× 23 0.3× 48 0.6× 14 445
Chantal C. H. J. Kuijpers Netherlands 13 170 0.5× 117 0.8× 78 0.6× 57 0.7× 50 0.6× 23 356
Bao‐Ning Zhang China 8 295 0.8× 58 0.4× 184 1.5× 80 1.0× 24 0.3× 11 445
Judy Caines Canada 10 197 0.6× 44 0.3× 135 1.1× 105 1.3× 64 0.8× 15 381

Countries citing papers authored by Josefa Ibáñez

Since Specialization
Citations

This map shows the geographic impact of Josefa Ibáñez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josefa Ibáñez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josefa Ibáñez more than expected).

Fields of papers citing papers by Josefa Ibáñez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josefa Ibáñez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josefa Ibáñez. The network helps show where Josefa Ibáñez may publish in the future.

Co-authorship network of co-authors of Josefa Ibáñez

This figure shows the co-authorship network connecting the top 25 collaborators of Josefa Ibáñez. A scholar is included among the top collaborators of Josefa Ibáñez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josefa Ibáñez. Josefa Ibáñez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vanaclocha‐Espí, Mercedes, Josefa Ibáñez, Dolores Salas, et al.. (2024). Impact of different age ranges on the benefits and harms of the breast cancer screening programme by the EU-TOPIA tool. European Journal of Public Health. 34(4). 806–811.
2.
Vanaclocha‐Espí, Mercedes, et al.. (2024). Interaction of sedentary behaviour and educational level in breast cancer risk. PLoS ONE. 19(5). e0300349–e0300349.
3.
Vanaclocha‐Espí, Mercedes, Josefa Ibáñez, Ana Molina‐Barceló, et al.. (2021). Optimal cut-off value for detecting colorectal cancer with fecal immunochemical tests according to age and sex. PLoS ONE. 16(7). e0254021–e0254021. 8 indexed citations
4.
Ibáñez, Josefa, et al.. (2021). ¿Aceptan las mujeres de la Comunidad Valenciana la auto-toma como forma de cribado de cáncer de cérvix?. Revista Española de Salud Pública. 95(95). 55. 1 indexed citations
5.
Ibáñez, Josefa, et al.. (2021). [Do women in the Valencian Community accept self-sampling as a form of cervical cancer screening?]. PubMed. 95. 2 indexed citations
6.
Ibáñez, Josefa, et al.. (2021). Resultados de 10 años del Programa de Prevención de Cáncer Colorrectal en la Comunitat Valenciana. Revista Española de Salud Pública. 95(95). 107. 1 indexed citations
7.
Molina‐Barceló, Ana, et al.. (2021). Desigualdades de acceso a los programas de cribado del cáncer en España y cómo reducirlas: datos de 2013 y 2020. Revista Española de Salud Pública. 95(95). 58. 3 indexed citations
8.
Vanaclocha‐Espí, Mercedes, Josefa Ibáñez, Ana Molina‐Barceló, et al.. (2018). Risk factors for severe complications of colonoscopy in screening programs. Preventive Medicine. 118. 304–308. 9 indexed citations
9.
Portillo, Isabel, Eunate Arana‐Arri, Isabel Idígoras, et al.. (2017). PROYECTO CRIBEA: LESIONES DETECTADAS EN SEIS PROGRAMAS POBLACIONALES DE CRIBADO DE CÁNCER COLORRECTAL EN ESPAÑA. SHILAP Revista de lepidopterología. 2 indexed citations
10.
Portillo, Isabel, Eunate Arana‐Arri, Isabel Idígoras, et al.. (2017). [Lesions Detected in Six Spanish Colorectal Cancer Screening Population Based Programmes. CRIBEA Project. Spain].. PubMed. 91. 7 indexed citations
11.
Vanaclocha‐Espí, Mercedes, Josefa Ibáñez, Ana Molina‐Barceló, et al.. (2017). Factors influencing participation in colorectal cancer screening programs in Spain. Preventive Medicine. 105. 190–196. 10 indexed citations
12.
Baré, Marisa, Dolores Salas, Melcior Sentís, et al.. (2015). Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program. Breast Cancer Research and Treatment. 154(2). 403–415. 36 indexed citations
13.
Domingo, Laia, Dolores Salas, Raquel Zubizarreta, et al.. (2014). Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain. Breast Cancer Research. 16(1). R3–R3. 61 indexed citations
14.
Blanch, Jordi, María Sala, Josefa Ibáñez, et al.. (2014). Impact of Risk Factors on Different Interval Cancer Subtypes in a Population-Based Breast Cancer Screening Programme. PLoS ONE. 9(10). e110207–e110207. 22 indexed citations
15.
Domingo, Laia, Jordi Blanch, Dolores Salas, et al.. (2013). Clinical and radiological features of breast tumors according to history of false-positive results in mammography screening. Cancer Epidemiology. 37(5). 660–665. 4 indexed citations
16.
Salas, Dolores, Josefa Ibáñez, Marta Román, et al.. (2011). Effect of start age of breast cancer screening mammography on the risk of false-positive results. Preventive Medicine. 53(1-2). 76–81. 20 indexed citations
17.
18.
Ascunce, Nieves, et al.. (2010). Cancer screening in Spain. Annals of Oncology. 21. iii43–iii51. 101 indexed citations
19.
Fidalgo, José Alejandro Pérez, Isabel Chirivella, Josefa Ibáñez, et al.. (2008). Impact of mammography screening programme in the breast cancer population of the Region of Valencia (Spain). Clinical & Translational Oncology. 10(11). 745–752. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026